相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
LESS IS MORE Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
Morten L. Hansen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)
Keith A. A. Fox et al.
EUROPEAN HEART JOURNAL (2010)
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
Michael Rud Lassen et al.
LANCET (2010)
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement.
Michael Rud Lassen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
John H. Alexander et al.
CIRCULATION (2009)
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
Rikke Sorensen et al.
LANCET (2009)
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
J. L. Mega et al.
LANCET (2009)
Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
Michael Rud Lassen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Apixaban, an oral, direct and highly selective factor Xa inhibitor:: in vitro, antithrombotic and antihemostatic studies
P. C. Wong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement
M. R. Lassen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Universal definition of myocardial infarction
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Pexelizumab and the APEX AMI trial
Paul W. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
Pasi P. Karjalainen et al.
EUROPEAN HEART JOURNAL (2007)
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
Keith A. A. Fox et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25 307 patients
F Andreotti et al.
EUROPEAN HEART JOURNAL (2006)
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
BS Lewis et al.
AMERICAN HEART JOURNAL (2005)
Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: Meta-analysis with estimates of risk and benefit
MB Rothberg et al.
ANNALS OF INTERNAL MEDICINE (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes - Results from the CRUSADE quality improvement initiative
DL Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Warfarin, aspirin, or both after myocardial infarction.
M Hurlen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial
RF van Es et al.
LANCET (2002)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)
分享论文
